Close menu




July 20th, 2021 | 11:28 CEST

Mineworx Technologies, Siemens, Bayer - Innovation is the trump card

  • Investments
Photo credits: mineworx.net

Since 2005, the Boston Consulting Group has annually selected the world's 50 most innovative companies. The list reads like a "Who's Who" of international heavyweights: Apple, Alphabet, Amazon, Microsoft and Tesla took the top 5 spots in 2021. In total, the United States was able to occupy 26 of the 50 spots - that is an impressive number. But German companies also find their way into the illustrious circle 9 times, including Siemens and Bayer. Why is innovation so important? Innovation is a key success factor for a company to achieve above-average results and differentiate itself from competitors. For this reason, we take a closer look at innovative companies in different industries. Who is your favorite?

time to read: 2 minutes | Author: Carsten Mainitz
ISIN: MINEWORX TECHNOLOGIES LTD | CA6034652041 , SIEMENS AG NA O.N. | DE0007236101 , BAYER AG NA O.N. | DE000BAY0017

Table of contents:


    MINEWORX TECHNOLOGIES LTD - Innovative recycling process

    The Canadians specialize in the circular economy in the mining, electronic scrap and automotive catalytic converter sectors. Mineworx has developed an innovative and patented process for recycling diesel catalysts and is now taking the next steps towards commercialization. The Company is addressing a market with more than 100 million catalysts worldwide. Around 80% of the world's production of palladium is used for catalytic converters. Palladium and platinum prices are significantly higher than gold.

    Mineworx's process does not take the conventional smelting route but instead extracts platinum and palladium specifically from ground core materials of the catalysts and through a chemical process. The Company's thoroughly planned and fully financed pilot plant is expected to be operational by the beginning of the current year's third quarter and generate initial revenues by the end of 2021. The resulting concentrate will then be sold to a refinery. The Canadians' collaboration partner for commercialization is Davis Recycling. The Company is active in 13 US states and has been recycling catalysts for 20 years. If initial production is successful, plants are planned throughout North America.

    Recently, Mineworx and Davis Recycling formed a joint venture, PGM Renewal LLC, with Mineworx holding a 55% interest and Davis a 45% interest. Mineworx will contribute its technologies and processes, according to the joint venture agreement, and Davis will be responsible for supply chain management and material preparation for the diesel catalysts. Profits generated from platinum and palladium recovery from the used diesel catalysts will be shared among the partners in proportion to their respective shareholdings.

    The commercialization of the diesel catalyst recycling business in the US could easily lead to a revaluation of Mineworx Technologies if the business takes off well. Currently, the Company is valued at only CAD 31 million.

    SIEMENS AG - Focused to grow faster

    The new Siemens CEO, Roland Busch, has formulated ambitious goals for the technology group in the medium term. Following many years of restructuring and the spin-off of units such as Infineon and Osram or the completed spin-off of the energy or medical technology business, the Group is now focusing on a new core business that is strongly linked to the area of digitalization.

    Software, automation and digital infrastructure are core elements to grow faster than the industry in the future. "Our growth drivers are digitalization, automation and sustainability. In this context, our core business and our digital business are mutually reinforcing," Busch said. Shareholders are also set to benefit from a share buyback program of up to EUR 3 billion by 2026 and a rising dividend. At prices around EUR 125, the Bavarians are valued at EUR 107 billion.

    BAYER - A long tradition

    Bayer is a life science company with a history of more than 150 years. The Group's core competencies are in the fields of health care and agriculture. The approach is to deliver products and services for a growing and aging population with the central areas of health and nutrition. The Company focuses its research and development activities on improving people's quality of life by preventing, alleviating and curing diseases. The spectrum of its business activities thus extends far beyond Covid, which is currently the subject of widespread media coverage, with its partnership with CureVac. Currently, the DAX-listed Company is valued at EUR 48 billion at prices around EUR 49.


    Innovation is a central cornerstone for the economic success of a company. Sooner or later, this is also reflected in the share price. Siemens and Bayer are suitable investments for more conservative investors, while Mineworx Technologies is suited to more risk-averse investors. The share of Mineworx Technologies could be on the verge of a revaluation.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by Nico Popp on February 4th, 2026 | 07:30 CET

    History repeats itself: Why Antimony Resources now offers the Lynas Rare Earths opportunity of 2010 and could benefit like Cameco

    • Mining
    • antimony
    • Investments
    • CriticalMetals
    • Defense
    • RareEarths

    There are moments when geopolitical ruptures disrupt entire industries. Anyone who remembers 2010 knows what we are talking about: at that time, China effectively shut down exports of rare earths amid a dispute over the Senkaku Islands. Western industry was in shock, prices exploded, and a small, hitherto little-noticed Australian explorer named Lynas Rare Earths became the Western world's only hope overnight. Today, 15 years later, we are experiencing déjà vu: this time, however, the focus is not on neodymium, but on antimony – the forgotten metal without which the defense industry would grind to a halt. Once again, China dominates the market, once again export restrictions are being used as a political weapon, and once again the West is desperately searching for a safe alternative. This is where Antimony Resources comes into play. The company is now at exactly the same point where Lynas was before its legendary rise: it controls an antimony project in a secure jurisdiction that can break dependence on the East.

    Read

    Commented by Nico Popp on February 4th, 2026 | 07:05 CET

    Solution to a billion-dollar problem: MustGrow Biologics validates business model – Revolutionary news also for Bayer and Corteva Agriscience

    • Agriculture
    • agritech
    • crops
    • Investments

    Canola is to Canada what oil is to Saudi Arabia: an economic driver of enormous proportions. With an estimated production value of around CAD 14 billion in 2025, the yellow-flowering crop is the "green gold" of the prairie. Yet this billion-dollar market is in danger: clubroot, an aggressive soil-borne disease, threatens crops and is already causing annual losses exceeding CAD 500 million. Previous solutions have reached their biological limits, but now the Canadian AgriTech company MustGrow Biologics is reporting a decisive success. As the company announced on Tuesday, its proprietary TerraMG™ technology has not only suppressed the disease in large-scale field trials, but also significantly increased yields. For agricultural giants like Bayer and Corteva, this could be the decisive lever to protect their high-performance seed varieties over the long term.

    Read

    Commented by André Will-Laudien on February 3rd, 2026 | 07:25 CET

    SILVER CRASH - From USD 122 to USD 72! Time to sharpen your knives with TKMS, CSG, Silver Viper, and thyssenkrupp

    • Mining
    • Silver
    • Defense
    • Steel
    • Investments

    The explosive rise in the price of silver, which rose almost in a straight line from around USD 35 to USD 122 by the end of last week, is now taking its speculative toll. The precious metal has soared by more than 300% within 14 months, accompanied by widespread rumors of huge short positions and extreme problems for the futures exchanges in terms of material supply. The fact remains that silver has been used for several years across various high-tech industries, from wind power and e-mobility to state-of-the-art defense technology. Manufacturers are also said to have been spotted on the market making large cover purchases due to impending physical shortages. Industry sources report a possible deficit of over 1 billion ounces in the March settlement – equivalent to around 125% of total annual production. In addition to the exciting silver explorer Silver Viper, we also analyze thyssenkrupp, its subsidiary TKMS, and the newcomer to the stock market, CSG. It is worth reading on.

    Read